Literature DB >> 10808617

[Apoptosis in trophoblast of patients with recurrent spontaneous abortion of unidentified cause].

F Vadillo Ortega1, M A Avila Vergara, C Hernández Guerrero, F Arechavaleta Velasco, J Beltrán Montoya.   

Abstract

Recurrent spontaneous abortion of unidentified cause or idiopatic is an important problem of reproduction health. In this study, the study has been started of one of the mechanisms that could act in the pathology of human pregnancy. The general hypothesis proposed, is that in the case of patients with recurrent spontaneous abortion of non identified cause (RSA) there are phenomenons in the materno/fetal/placentary means that manifest themselves in harm to the functionality and/or vitality of placentary tissue. The hypothesis was consistent with the finding of massive activation of cellular death in all the cases with RSA studied in this work.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10808617

Source DB:  PubMed          Journal:  Ginecol Obstet Mex        ISSN: 0300-9041


  4 in total

Review 1.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 2.  The role of inflammation and infection in preterm birth.

Authors:  Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Juan Pedro Kusanovic; Lara Friel; Sonia Hassan
Journal:  Semin Reprod Med       Date:  2007-01       Impact factor: 1.303

3.  Goniothalamus species: a source of drugs for the treatment of cancers and bacterial infections?

Authors:  Christophe Wiart
Journal:  Evid Based Complement Alternat Med       Date:  2007-09       Impact factor: 2.629

4.  Novel mechanism of miRNA-365-regulated trophoblast apoptosis in recurrent miscarriage.

Authors:  Wei Zhao; Wei-Wei Shen; Xiao-Mei Cao; Wen-Yan Ding; Lin-Ping Yan; Ling-Juan Gao; Xiu-Ling Li; Tian-Ying Zhong
Journal:  J Cell Mol Med       Date:  2017-04-10       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.